As of 2025-12-21, the Relative Valuation of Neogenomics Inc (NEO) is (26.99) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.83 USD, the upside of Neogenomics Inc based on Relative Valuation is -328.1%.
The range of the Relative Valuation is (27.59) - (26.26) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.5x - 33.9x | 33.1x |
| Forward P/E multiples | 27.0x - 29.9x | 28.4x |
| Fair Price | (27.59) - (26.26) | (26.99) |
| Upside | -333.2% - -321.9% | -328.1% |
| Date | P/E |
| 2025-12-19 | -13.49 |
| 2025-12-18 | -13.32 |
| 2025-12-17 | -13.26 |
| 2025-12-16 | -13.31 |
| 2025-12-15 | -13.59 |
| 2025-12-12 | -13.51 |
| 2025-12-11 | -13.42 |
| 2025-12-10 | -13.68 |
| 2025-12-09 | -13.46 |
| 2025-12-08 | -13.35 |
| 2025-12-05 | -13.57 |
| 2025-12-04 | -13.88 |
| 2025-12-03 | -13.82 |
| 2025-12-02 | -13.76 |
| 2025-12-01 | -13.71 |
| 2025-11-28 | -13.80 |
| 2025-11-26 | -13.83 |
| 2025-11-25 | -14.07 |
| 2025-11-24 | -13.24 |
| 2025-11-21 | -13.09 |
| 2025-11-20 | -12.09 |
| 2025-11-19 | -11.72 |
| 2025-11-18 | -11.87 |
| 2025-11-17 | -11.65 |
| 2025-11-14 | -11.79 |
| 2025-11-13 | -11.41 |
| 2025-11-12 | -11.40 |
| 2025-11-11 | -11.88 |
| 2025-11-10 | -11.86 |
| 2025-11-07 | -11.49 |
| 2025-11-06 | -11.86 |
| 2025-11-05 | -11.89 |
| 2025-11-04 | -11.52 |
| 2025-11-03 | -11.15 |
| 2025-10-31 | -11.14 |
| 2025-10-30 | -11.05 |
| 2025-10-29 | -11.72 |
| 2025-10-28 | -11.31 |
| 2025-10-27 | -11.59 |
| 2025-10-24 | -12.17 |
| 2025-10-23 | -11.92 |
| 2025-10-22 | -11.79 |
| 2025-10-21 | -11.89 |
| 2025-10-20 | -12.08 |
| 2025-10-17 | -11.46 |
| 2025-10-16 | -11.72 |
| 2025-10-15 | -11.37 |
| 2025-10-14 | -10.70 |
| 2025-10-13 | -10.65 |
| 2025-10-10 | -10.38 |